touchPODCAST

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss the latest data on PD-1/PD-L1 inhibitors and what they mean for patients with EC. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Medical oncologist: Dr Antonio González-Martín This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education g...

touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care. The experts Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany Dr Emily Ruiz, Brigham and Women’s Hospital, Bo...

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts discuss evolving treatment options for patients with advanced basal cell carcinoma, and how novel immunotherapeutic approaches within the emerging clinical study landscape may improve patient care. The experts Prof. Axel Hauschild, University Hospital Schleswig-Holstein, Kiel, Germany Dr Emily Ruiz, Brigham and Women’s Hospital, Bost...

touchMDT for touchONCOLOGY Listen to a medical oncologist and an oncology nurse practitioner discuss how to involve the patient in treatment decisions and the role of the multidisciplinary team in keeping abreast of the latest data. The multidisciplinary team Medical oncologist: Dr David Planchard, France  Oncology nurse practitioner: Ms Beth Sandy, USA This touchPODCAST is for HCPs only. This act...

touchMDT for touchONCOLOGY Listen to a medical oncologist and a pathologist discuss the benefits of biomarker testing in early and locally advanced NSCLC. The multidisciplinary team Medical oncologist: Dr David Planchard, France  Molecular pathologist: Prof. Albrecht Stenzinger, Germany This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education gra...

touchMDT for touchONCOLOGY Listen to a medical oncologist, a pulmonologist and a thoracic surgeon as they assess the suitability of a patient with NSCLC for surgery and expanding treatment options. The multidisciplinary team Medical oncologist: Dr David Planchard, France  Pulmonologist: Prof. Johan Vansteenkiste, Belgium Thoracic surgeon: Dr Masahiro Tsuboi, Japan This touchPODCAST is for HCPs onl...

touchPANEL DISCUSSION for touchCARDIO Listen to leading experts discuss how patients can be best supported following a diagnosis of HFrEF, how to implement evidence-based therapies into practice including the potential impact of emerging therapies on treatment selection, and the role of biomarkers in diagnosing, monitoring and determining treatment course for individuals with HFrEF. The experts Pr...

touchCONGRESS for touchONCOLOGY Listen to Prof. Uwe Platzbecker (Germany) cover key data presented at EHA2021 Virtual on new and emerging treatments for the improvement of outcomes in higher-risk MDS and newly diagnosed AML, including expert insights and interpretation from Prof. Valeria Santini (Italy) and Prof. Andrew Wei (Australia). This touchPODCAST is for HCPs only. Funding for this touchPOD...

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guideline recommendations for the management of patients with dyslipidemia. The multidisciplinary team Cardiologist: Dr Constantine Kosmas, USA Primary care physician: Dr Yassir Javaid, UK  This touchPODCAST is for HCPs only. This activity is funded by an...

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help  The multidisciplinary team Endocrinologist: Professor Lawrence Leiter, Canada Cardiologist: Dr Constantine Kosmas, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medic...

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia  The multidisciplinary team Primary care physician: Dr Yassir Javaid, UK  Cardiologist: Dr Constantine Kosmas, USA Endocrinologist: Professor Lawrence Leiter, Canada This touchPODCAST is for HCPs only....

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the risk factors and lipoproteins associated with ASCVD and guideline recommendations for the management of patients with dyslipidemia The multidisciplinary team Cardiologist: Dr Constantine Kosmas, USA Primary care physician: Dr Yassir Javaid, UK  This touchPODCAST is for HCPs only. This activity is funded...

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help  The multidisciplinary team Endocrinologist: Professor Lawrence Leiter, Canada Cardiologist: Dr Constantine Kosmas, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independen...

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia  The multidisciplinary team Primary care physician: Dr Yassir Javaid, UK  Cardiologist: Dr Constantine Kosmas, USA Endocrinologist: Professor Lawrence Leiter, Canada This touchPODCAST is for HCPs only....

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts in breast cancer share their opinion on the latest data which may help guide the use of CDK4/6 inhibitors in HR+/HER2- advanced breast cancer. The experts Dr Luca Malorni - Hospital of Prato, Italy Prof. Aleix Prat - Hospital Clínic Barcelona, Spain Dr Barbara Pistilli - Gustave Roussy, Villejuif, France This touchPODCAST is for HCPs...

touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma and how biomarkers can inform treatment decisions. The experts Dr Michael Wechsler - National Jewish Health and University of Colorado, Denver, USA Dr Roland Buhl - Mainz University Hospital, Mainz, Germany Dr Flavia Hoyte - National Jewish Health and...

touchPANEL DISCUSSION for touchRESPIRATORY Listen to a panel of experts discuss using biologics to optimize outcomes for patients with type 2 asthma and how biomarkers can inform treatment decisions. The experts Dr Michael Wechsler - National Jewish Health and University of Colorado, Denver, USA Dr Roland Buhl - Mainz University Hospital, Mainz, Germany Dr Flavia Hoyte - National Jewish Health and...

touchCONGRESS for touchIMMUNOLOGY Walter Maksymowych (University of Alberta, Alberta, Canada) talks to touchIMMUNOLOGY about the results of the C-axSpAnd Study (NCT02552212). This 52-week placebo-controlled study aimed to identify demographic or baseline characteristics of patients with nr-axSpA that could be predictive of achieving a clinical response to treatment with certolizumab pegol. The abs...

touchEXPERT OPINIONS for touchONCOLOGY Listen to leading experts discuss how monoclonal antibody (MAb) biosimilars for solid tumours are developed and approved, and learn about the practical aspects of their use in oncology pharmacy. The experts Dr Paul Cornes - Comparative Outcomes Group, Bristol, UK Dr Joseph Bubalo - Oregon Health & Science University Hospital & Clinics, Portland, USA Mr Hisana...

touchCONGRESS for touchONCOLOGY Listen to key highlights from SABCS Virtual 2020.  This touchPODCAST is presented by Prof. Dr Nadia Harbeck.   We specifically focus on data presented at this congress describing CDK4/6 inhibitors in HR+/HER2- breast cancer and what these data could mean for clinical practice.  This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independen...

touchCONGRESS for touchONCOLOGY Listen to key highlights from ESMO Virtual 2020. This touchPODCAST is presented by Dr Catherine Kelly.  We specifically focus on data presented at this congress describing CDK4/6 inhibitors in HR+/HER2- breast cancer and what these data could mean for clinical practice.  This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medic...